RT Journal Article
SR Electronic
A1 Spevak, Aimee
T1 REGULATE-PCI Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 5
SP 12
OP 13
DO 10.1177/1559897715583815
UL http://mdc.sagepub.com/content/15/5/12.abstract
AB The REGULATE-PCI trial compared REG1, a novel factor IXa inhibitor system for patients undergoing percutaneous coronary intervention, with bivalirudin for safety and efficacy outcomes. After just under a year of data collection, an unexpected increase in severe allergic reaction to the REG1 system led to early termination of the trial.